Our lab clinches another win at the DIAC! Our project, B-ALIVE, explores new ways to engineer antibodies to be effective against cancer, and we think it can make a real breakthrough in cancer immunotherapy. We went through an intensive 10-week entrepreneurship course as part of the DIAC and got to meet great mentors, entrepreneurs and scientists along the way; the program culminated in a pitch competition by all 19 teams.
